Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CTMX > SEC Filings for CTMX > Form 8-K on 10-Jan-2017All Recent SEC Filings

Show all filings for CYTOMX THERAPEUTICS, INC.

Form 8-K for CYTOMX THERAPEUTICS, INC.


10-Jan-2017

Results of Operations and Financial Condition, Regulation FD Disclosure


Item 2.02.Results of Operations and Financial Condition

On January 10, 2017, CytomX Therapeutics, Inc. (the "Company") will be providing a corporate update, including the Company's preliminary (unaudited) cash balance of $182 million as of December 31, 2016, at the 35th Annual J.P. Morgan Healthcare Conference (the "JPMorgan Conference").

The information in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.



Item 7.01Regulation FD Disclosure

As referenced above, the Company will be giving a presentation at the JPMorgan Conference on January 10, 2017. A copy of the presentation, including a slide setting forth certain cautionary language intended to qualify the forward-looking statements included in the presentation, is furnished as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

The information in this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Security Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.



Item 9.01.Financial Information and Exhibits

(d) Exhibits

Exhibit 99.1 Presentation by Sean McCarthy, D.Phil., President and Chief Executive Officer of CytomX Therapeutics, Inc., at the 35th Annual J.P. Morgan Healthcare Conference.


  Add CTMX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CTMX - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.